Payden & Rygel Albemarle Corp Transaction History

Payden & Rygel

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Oct 07, 2024	SELL	$92.77 - $135.46 $129,878 - $189,644	-1,400 Closed	0 $0
Q1 2024 Oct 08, 2024	BUY	$108.73 - $146.89 $152,222 - $205,645	1,400 New	1,400 $184,000
Q2 2021 Aug 06, 2021	SELL	$143.7 - $176.01 $86,220 - $105,606	-600 Reduced 30.0%	1,400 $236,000
Q1 2021 May 13, 2021	SELL	$140.69 - $185.25 $35.3 Million - $46.5 Million	-250,900 Reduced 99.21%	2,000 $292,000
Q3 2020 Nov 10, 2020	BUY	$75.75 - $100.45 $19.2 Million - $25.4 Million	252,900 New	252,900 $22.6 Million

928

104M

8.36M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $12.6B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Payden & Rygel, based on Form 13F filings with the SEC.

Stay updated on Payden & Rygel with notifications on news.